1. "2019"
Formats
  1. Journal Article (2144)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2450)
  2. Solid Tumor Oncology Division (1408)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (937)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5611)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5611)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DNA damage response pathway alterations and clinical outcome in leiomyosarcoma
    Meeting Abstract

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Qin, L. X.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Somatic mutational profile of Merkel cell carcinoma treated with immune checkpoint blockade: Preliminary results from a planned multiplatform analysis
    Meeting Abstract

    Rosenbaum, E.; Kelly, C. M.; Barker, C. A.; Adamson, T.; Kiesler, H.; Hundal, J.; Paul, A. J.; McLellan, M. D.; Walker, J.; Tap, W. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ivosidenib (IVO; AG-120) in IDH1-mutant newly-diagnosed acute myeloid leukemia (ND AML): Updated results from a phase 1 study
    Meeting Abstract

    Roboz, G. J.; Dinardo, C. D.; Stein, E. M.; de Botton, S.; Mims, A. S.; Prince, G. T.; Altman, J. K.; Arellano, M. L.; Erba, H. P.; Pollyea, D. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer
    Meeting Abstract

    Rizvi, H.; Bandlamudi, C.; Schoenfeld, A. J.; Sauter, J. L.; Arbour, K. C.; Beras, A.; Egger, J. V.; Ladanyi, M.; Donoghue, M.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors
    Meeting Abstract

    Robinson, G. W.; Gajjar, A. J.; Gauvain, K. M.; Basu, E. M.; Macy, M. E.; Maese, L. D.; Sabnis, A. J.; Foster, J. H.; Shusterman, S.; Yoon, J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Real-world utilization of EGFR TKI therapies and treatment outcomes in patients with advanced EGFR-sensitizing mutation-positive NSCLC
    Meeting Abstract

    Riely, G. J.; Lovly, C. M.; Messina, C. G. M.; Bienert, S.; Alexander, K.; Pao, W.; Baxi, S.; Doebele, R. C.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Atezolizumab (atezo) plus bevacizumab (bev) versus sunitinib (sun) in pts with untreated metastatic renal cell carcinoma (mRCC) and sarcomatoid (sarc) histology: IMmotion151 subgroup analysis
    Meeting Abstract

    Rini, B. I.; Motzer, R. J.; Powles, T.; McDermott, D. F.; Escudier, B.; Donskov, F.; Hawkins, R. E.; Bracarda, S.; Bedke, J.; De Giorgi, U.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Blocking LILRB and KIR receptors by B57 open conformers induces potent antitumor activity and acts synergistically with checkpoint blockade inhibition
    Meeting Abstract

    Renner, C.; Curran, M. A.; Kolibaba, J.; Liu, Y.; Petrausch, U.; Zippelius, A.; Stenner, F.; Rafiei, A.; Belaunzaran, O. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab in resectable non-small cell lung cancer: Extended follow-up and molecular markers of response
    Meeting Abstract

    Reuss, J. E.; Smith, K. N.; Anagnostou, V.; Zhang, J.; Zahurak, M.; Caushi, J.; Chan, H. Y.; Guo, H.; Hellmann, M. D.; Pardoll, D. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) plus radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM)
    Meeting Abstract

    Reardon, D. A.; Kaley, T. J.; Dietrich, J.; Clarke, J. L.; Dunn, G.; Lim, M.; Cloughesy, T. F.; Gan, H. K.; Park, A. J.; Schwarzenberger, P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save